4.2 Review

Alzheimer's beta-secretase cleaves a glycosyltransferase as a physiological substrate

Journal

GLYCOCONJUGATE JOURNAL
Volume 20, Issue 1, Pages 59-62

Publisher

SPRINGER
DOI: 10.1023/B:GLYC.0000016743.25495.45

Keywords

Alzheimer's disease; amyloid precursor protein; amyloid beta-peptide; beta-secretase; alpha 2,6-sialyltransferase; glycosyltransferases; proteolytic cleavage; alpha 2,6-sialylation; Golgi apparatus; secretion; CD22/Siglec-2 signaling

Ask authors/readers for more resources

Alzheimer's beta-secretase (BACE1) is a membrane-bound protease that cleaves the amyloid precursor protein (APP) in the trans-Golgi network, an initial step in the pathogenesis of Alzheimer's disease. Although BACE1 is distributed among various tissues including brain, its physiological substrate other than APP have not been identified. We have recently found that when BACE1 was overexpressed in COS cells together with alpha2,6-sialyltransferase (ST6Gal I), the secretion of ST6Gal I markedly increased, suggesting that BACE1 cleaves ST6Gal I as a physiological substrate. Thus BACE1 is the first identified protease that is responsible for the cleavage and secretion of glycosyltransferases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available